Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In High-Risk Neutropenic Patients With Fever And A Positive Panfungal Polymerase Chain Reaction Assay (IDEA Study)

NCT00150345 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00150345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00150345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In High-Risk Neutropenic Patients With Fever And A Positive Panfungal Polymerase Chain Reaction Assay (IDEA Study)
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
April 30, 2009
Enrollment
147 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

possible fungal infection